Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Oct 1:12:1663998.
doi: 10.3389/fmolb.2025.1663998. eCollection 2025.

The role of antioxidants in facial nerve injury

Affiliations
Review

The role of antioxidants in facial nerve injury

Jae Min Lee et al. Front Mol Biosci. .

Abstract

Oxidative stress contributes to the pathogenesis of facial nerve injury (FNI), yet the role of antioxidants in driving regeneration and functional recovery remains incompletely defined. This narrative review synthesizes studies published between 2008 and 2025 that evaluated antioxidant interventions in FNI across animal and limited human contexts. We systematically searched five databases and included 19 studies assessing oxidative stress markers and neural outcomes following antioxidant administration. To avoid overgeneralization, we stratified findings by injury model-crush/compression, transection with anastomosis, and ischemic/viral-and by primary endpoints (electrophysiology/behavior vs. histology/biochemistry), and, where reported, by intervention timing and dose. Antioxidants commonly reduced reactive oxygen species and modulated survival and inflammatory pathways, supporting neuroprotection and, in some models, improved electrophysiological or behavioral readouts. However, benefits varied by model and regimen: crush injuries showed earlier functional gains, whereas transection models more often demonstrated histological improvement without consistent short-term functional recovery; ischemic/viral studies frequently lacked standardized electrophysiological confirmation. Outcomes were also contingent on timing and dose (with earlier initiation and moderate dosing generally more favorable), and select combinations showed additive effects in preclinical settings. Overall, the evidence is predominantly preclinical, heterogeneous in dosing/timing/formulations, and limited by small sample sizes and inconsistent functional outcomes. Antioxidant strategies should therefore be considered hypothesis-generating rather than clinically recommendable at this time. Future research should use model-appropriate, standardized functional endpoints, prespecify timing/dose exploration, evaluate rational combinations, and conduct well-powered clinical trials to establish efficacy, optimal use, and safety.

Keywords: antioxidants; facial nerve injury; nerveregeneration; oxidative stress; reactive oxygen species.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Review flow diagram.
FIGURE 2
FIGURE 2
Antioxidant interventions in FNI.

References

    1. Abdolmaleki A., Zahri S., Bayrami A. (2020). Rosuvastatin enhanced functional recovery after sciatic nerve injury in the rat. Eur. J. Pharmacol. 882, 173260. 10.1016/j.ejphar.2020.173260 - DOI - PubMed
    1. Adamu A., Li S., Gao F., Xue G. (2024). The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front. Aging Neurosci. 16, 1347987. 10.3389/fnagi.2024.1347987 - DOI - PMC - PubMed
    1. Alipour M., Gholami M. R., Jafari Anarkooli I., Sohrabi D., Tajki J., Pourheidar M. (2011). Intraperitoneal aminoguanidine improves sciatic nerve ischemia-reperfusion injury in male sprague-dawley rats. Cell Mol. Neurobiol. 31, 765–773. 10.1007/s10571-011-9682-5 - DOI - PMC - PubMed
    1. Alsharif I., Boukhzar L., Lefranc B., Godefroy D., Aury-Landas J., Rego J.-L. do, et al. (2021). Cell-penetrating, antioxidant SELENOT mimetic protects dopaminergic neurons and ameliorates motor dysfunction in Parkinson’s disease animal models. Redox Biol. 40, 101839. 10.1016/j.redox.2020.101839 - DOI - PMC - PubMed
    1. Baicus C., Purcarea A., von Elm E., Delcea C., Furtunescu F. L. (2024). Alpha-lipoic acid for diabetic peripheral neuropathy. Cochrane Database Syst. Rev. 1, CD012967. 10.1002/14651858.CD012967.pub2 - DOI - PMC - PubMed

LinkOut - more resources